An introduction to In Vitro Maturation
In Vitro Maturation (IVM) is a revolutionary fertility treatment, which has been pioneered by our Scientific Director, Professor R C Chian. It involves the collection of immature eggs, which are then matured in the lab. By this method, it is possible to collect multiple eggs without giving hormone stimulation. We were the first fertility clinic in Europe to offer Natural Cycle IVF with IVM.
The first step to finding out which treatment option will give you the best chance of success is coming in for an Initial Scan and Consultation.Book now
What is IVM?
During each menstrual cycle, usually only a single follicle (egg sac) grows to the ovulation stage to release an egg for potential fertilisation. However, there are several small follicles called antral follicles in the ovary which contain immature eggs. With IVM these can be collected and matured in the lab. Immature eggs are matured in the laboratory using special and advanced culture conditions to create several embryos.
Advantages of Natural IVF Treatment
Who is suitable for this Treatment?
This treatment can be used for anyone who is ovulating and who is recommended to do IVM by one of our doctors. It can be particularly useful for people for whom time is short, or who are unable to take fertility medication (due to an oestrogen dependent tumour for example).
Natural Cycle IVF with IVM is also a successful alternative for women with Polycystic Ovaries (PCO) or Polycystic Ovarian Syndrome (PCOS). In general, the clinical pregnancy rates are 30-35% in infertile women with PCO or PCOS, based on approximately 1,000 cycles of IVM-treatment.
'A combination of three things attracted me to CREATE.'
The first one was their more natural and less invasive approach to IVF with reduced amount of drugs. Number two was the quality of their internationally renowned consultants, and number three was their treatment cost. Whilst success rates was also a factor of choice, it was not as important a criteria to me as I first anticipated when I found out the reported figures were often reflective of the clinics’ unwillingness to accept patients with very low chance of success and therefore could not be compared on a like-for-like basis.